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Objective: The aim of this study was to compare the knowledge, attitude and barriers of pharmacy 
technicians and pharmacists toward pharmacovigilance, adverse drug reactions (ADRs) and 
ADR reporting in community pharmacies in Yemen.
Methods: This cross-sectional survey was conducted among community pharmacists and 
pharmacy technicians in the capital of Yemen, Sana’a. A total of 289 community pharmacies 
were randomly selected. The validated and pilot-tested questionnaire consisted of six sections: 
demographic data, knowledge about pharmacovigilance, experience with ADR reporting, 
attitudes toward ADR reporting, and the facilitators to improve ADR reporting.
Results: A total of 428 pharmacy technicians and pharmacists were contacted and 179 went 
on to complete a questionnaire (response rate: 41.8%). Of the 179 respondents, 21 (11.7%) 
were pharmacists and 158 (88.3%) were pharmacy technicians, of which, 176 (98.3%) were 
male and 3 (1.7%) were female. The mean age of the respondents was 25.87±2.63 years. There 
was a significant difference between the pharmacists and pharmacy technicians in terms of 
knowledge scores (P,0.05). The mean knowledge scores for pharmacists was 3.33±2.852 
compared to 0.15±0.666 for pharmacy technicians. With regard to attitudes toward ADR 
reporting, all pharmacists (100%) showed a positive attitude, while only 43% of pharmacy 
technicians showed a positive attitude.
Conclusion: Pharmacists have a significantly better knowledge than pharmacy technicians with 
regard to pharmacovigilance. More than half of pharmacy technicians showed a negative attitude 
toward ADR reporting. Therefore, educational interventions and training is very important for 
community pharmacists and pharmacy technicians in Yemen to increase their awareness and 
participation in ADR reporting.
Keywords: pharmacovigilance, adverse drug reactions, knowledge, attitude, community 
pharmacy, Yemen
Background
The World Health Organization (WHO) defines pharmacovigilance as “the science 
and activities relating to the detection, assessment, understanding and prevention of 
adverse effects or any other possible drug-related problems”.1 Pharmacovigilance 
is essential for the safe, rational, as well as cost-effective utilization of medicines 
worldwide; it plays an important role in improving the clinical outcomes and also 
decreasing mortality and morbidity rates.2 The success of pharmacovigilance centres 
depend on the rate of effective and spontaneous reporting of suspected adverse 
drug reactions (ADRs), as is considered the core component of pharmacovigilance 
activities.3–5 ADRs is defined by WHO as “any noxious, unintended, and undesired 
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effect of drug that occurs as a result of treatment with drug 
at normal doses used in man for diagnosis, prophylaxis, 
and treatment”.6 ADRs are considered a major cause of 
patients’ morbidity, mortality, hospital admissions, as well 
as increasing length of hospitalization and cost of treatment.6 
Literature demonstrates the importance of involving 
pharmacists in ADR reporting and considered pharma-
cists the most valuable sources of spontaneous reporting 
of ADRs.7–9
Community pharmacies in Yemen are considered as the 
most accessible and affordable health care facility to patients. 
This gives both licensed community pharmacists (BPharm 
holders) and pharmacy technicians working under the 
pharmacists supervision (diploma holders) the opportunity 
to detect and report ADRs more than any other health care 
professional.10,11 The Yemeni Pharmacovigilance Centre in 
Yemen was established in the capital, Sana’a, in early 2011 
serving as a national centre to collect, compile and analyze 
data on ADRs; identification of risk factors and possible 
mechanisms underlying adverse reactions; as well as drug 
quality surveillance.12
Underreporting is considered one of the major challenges 
of the Yemeni Pharmacovigilance Centre. ADR knowledge 
among health care professionals is one of the major factors 
affecting ADRs reporting. Pharmacists, as well as other 
health care professionals, cannot participate effectively 
in ADR reporting without sufficient knowledge of ADRs 
and ADR reporting process. Literature review shows that 
health care professionals, including pharmacists, have a 
poor knowledge regarding pharmacovigilance.13,14 There is 
a lack of studies about knowledge and attitude of community 
pharmacy technicians toward pharmacovigilance and ADR 
reporting in Yemen. Therefore, the aim of this study was to 
assess the knowledge, attitude and barriers of community 
pharmacists, as well as pharmacy technicians, toward phar-
macovigilance, and ADR reporting in Yemen.
Methods
A cross-sectional study was conducted over a period of 
3 months among community pharmacists and pharmacy 
technicians in Sana’a, Yemen.
sample size
According to the annual reports of the Ministry of Public Health 
and Population 2011, there were 1,160 community pharma-
cies in the capital, Sana’a.14,15 Based on this report, a random 
sample of 289 community pharmacies were selected, this was 
to have an estimate of precision at a 95% confidence interval 
(CI), with α=0.05.
study tools
This cross-sectional survey was conducted using a self- 
administered questionnaire given face-to-face by the research-
ers. The questionnaire was developed and validated based on 
the information from literature.16–18
The questionnaire was pilot tested on a convenience 
sample of 6 pharmacists and 4 pharmacy technicians to test 
the validity of the questionnaire. The final questionnaire com-
prised of six sections. Section one included the demographic 
characteristics of respondents, qualifications and experience. 
Section two included ten open ended questions to evaluate 
the knowledge of the participants toward pharmacovigi-
lance, ADRs and ADR reporting. Section three contained 
two questions exploring the experience of participants with 
ADRs and its reporting. Section four was looking at the 
attitude of participants toward pharmacovigilance and ADR 
reporting. Section five looked at determining the barriers of 
reporting ADRs. Section six aimed at exploring the factors 
that would encourage community pharmacy technicians in 
Yemen to report ADRs.
A score of 1 and 0 was given for each correct or incorrect 
answer, respectively, the total score for each participant was 
the summation of the scores in each section. In the knowledge 
section, scores could range from zero to ten and were trichoto-
mized into three levels: good knowledge (score $7), moderate 
knowledge (score 5–6), and poor knowledge (score #4). 
Regarding attitudes, barriers, and factors that encourage ADRs 
reporting, a 4-point Likert scale was used (A: agree; SA: 
strongly agree; D: disagree; and SD: strongly disagree).
The attitude evaluation had a maximum score of 13. 
A score of 1 and 0 was given for each positive (strongly agree, 
agree) or negative answer (disagree, strongly disagree), 
respectively. Total scores were calculated for each partici-
pant. A total score .7 was considered as a positive attitude, 
a score #7 were considered as a negative attitude.
All community pharmacy technicians without an appro-
priate certification or diploma in pharmacy were excluded 
from this study.
ethical approval
This study was approved by the Ethics Committee of Univer-
sity of Science and Technology, Yemen, and also by the man-
agers of the enrolled community pharmacies. Furthermore, 
all respondents were fully informed and gave their written 
informed consent before participating in the study.
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statistical analysis
Demographic variables and experiences of participants 
included in the study were examined on a descriptive basis. 
Percentages and frequencies were used for the categorical 
variables, while mean and standard deviation were calculated 
for the continuous variables. To examine for differences 
between pharmacists and pharmacy technicians in terms 
of knowledge, attitude and barriers to ADRs reporting, a 
Student’s t-test was used to compare continuous variables, 
whereas a Pearson’s chi square test/Fisher’s exact test was 
used to compare categorical variables. All analyses were 
performed using SPSS statistical software version 18 (SPSS 
Inc., Chicago, IL, USA). P-values ,0.05 was considered to 
indicate statistical significance.
Results
A total of 428 community pharmacists and pharmacy 
technicians were contacted, with 179 completing the ques-
tionnaire. Of the 179 respondents, 21 (11.7%) were phar-
macists and 158 (88.3%) were pharmacy technicians, of 
which 176 (98.3%) were male and 3 (1.7%) were female. 
One-hundred-and-seventy-seven respondents (98.9%) had 
graduated in Yemen. The mean age of the respondents was 
25.87±2.63 years. A majority of the respondents (108 [60.3%]) 
had #3 years work experience while 71 respondents (39.7%) 
had .3 years work experience.
Knowledge about pharmacovigilance, 
aDRs and aDR reporting in Yemen
Findings of this study showed significant differences between 
the pharmacists and pharmacy technicians in terms of 
understanding the concept and importance of pharmacovigi-
lance, ADRs and its type, the difference between ADRs 
and side effects, who should report ADRs, the reporting 
procedures, establishment year, and the location of the 
Pharmacovigilance Centre in Yemen (P,0.05). The phar-
macists answered the knowledge related questions better 
than pharmacy technicians. There was no significant differ-
ence between pharmacists and pharmacy technicians with 
regard to the question “What is the objectives of the Phar-
macovigilance Centre in Yemen?” (P=0.117), with only one 
pharmacist answering this question correctly. There was a 
significant difference between the pharmacists and pharmacy 
technicians in terms of knowledge total scores (P,0.05). 
The mean knowledge scores for pharmacists was 3.33±2.852 
compared to 0.15±0.666 for pharmacy technicians. There 
was a significant difference between the pharmacists and 
pharmacy technicians in terms of good knowledge (P,0.05). 
Five pharmacists (23.8%) had good knowledge, while two 
(1.3%) pharmacy technicians had moderate knowledge, and 
98.7% had poor knowledge. Table 1 shows the comparison 
between pharmacists and pharmacy technicians in terms of 
knowledge related questions.
aDR reporting experience among 
community pharmacists and pharmacy 
technicians in Yemen
The findings of this study showed that no pharmacy techni-
cians and only nine pharmacists (42.9%) had observed ADRs 
in their practice. The most common ADRs they detected were 
allergy and diarrhea. However, no ADRs were reported.
Table 1 Comparison between pharmacists and pharmacy technicians in terms of knowledge related questions
Knowledge questions Pharmacists
(N=21),  
n (%)
Pharmacy 
technicians
(N=158), 
n (%)
P-value*
What is pharmacovigilance? 5 (23.8) 2 (1.3) 0.001*
What is aDRs? 12 (57.1) 2 (1.3) 0.001*
how does an aDR differ from a side effect? 12 (57.1) 2 (1.3) 0.001*
What are the types of aDRs? 5 (23.8) 0 (0) 0.001*
Why is pharmacovigilance important? 5 (23.8) 1 (0.6) 0.001*
Who should report aDRs? 21 (100) 14 (8.9) 0.001*
how should a report on aDRs be done? 5 (23.8) 2 (1.3) 0.001*
When was the Pharmacovigilance Centre in Yemen established? 2 (9.5) 0 (0) 0.013*
Where is the location of the Pharmacovigilance Centre in Yemen? 2 (9.5) 0 (0) 0.013*
What is the objectives of the Pharmacovigilance Centre in Yemen? 1 (4.8) 0 (0) 0.117*
Total score, mean ± sD 3.33±2.852 0.15±0.666 0.001*
good knowledge score 5 (23.8) 0 (0) 0.001*
Note: *Chi-square test or Fisher’s exact test.
Abbreviation: aDRs, adverse drug reactions.
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attitude of community pharmacy 
technicians in Yemen toward 
pharmacovigilance and aDRs reporting
The findings of this study showed no significant difference 
between the pharmacists and pharmacy technicians in terms 
of attitude toward the question “I believe that pharmacovigi-
lance is important” (P=0.11). The majority of pharmacists 
(61.9%) believed that pharmacovigilance is important, 
while only 43% pharmacy technicians believed that pharma-
covigilance is important. There was a significant difference 
between pharmacists and pharmacy technicians in terms of 
believing that reporting ADRs is part of their professional 
duties (P,0.05). The majority of pharmacists (76.2%) felt 
that reporting ADRs was part of their professional duties com-
pared to only 27.2% of pharmacy technicians. There was no 
significant difference between the pharmacists and pharmacy 
technicians in terms of attitude toward the question “I have 
to be sure the ADR is related to the drug before reporting” 
(P=0.14). There was a significant difference between the 
pharmacists and pharmacy technicians in terms of attitude 
toward reporting ADRs related to over the counter products 
(P,0.05). Only five pharmacists (23.8%) said that they would 
report an event, while only two pharmacy technicians (1.3%) 
said that they would report it. There were no significant dif-
ferences between pharmacists and pharmacy technicians in 
terms of attitude toward reporting ADRs that caused hospi-
talization, life-threatening situations, a congenital anomaly, 
persistent disability or incapacity, or death (P=1.00).
The majority of pharmacists, as well as pharmacy techni-
cians, said that they would report these ADRs. There was a 
significant difference (P,0.05) between pharmacists and 
pharmacy technicians in terms of attitude toward the fol-
lowing questions: “I report to get more insight into ADR 
questions that I come across in my practice”; “I report to 
show the patient that their concern is being taken seriously”; 
“I always report ADRs because it is part of pharmaceutical 
care” and “Consulting the physician is important before 
reporting an ADR”. Generally, pharmacists showed bet-
ter attitudes toward the above four mentioned questions 
than pharmacy technicians. There was a significant differ-
ence between the pharmacists and pharmacy technicians 
in terms of attitude total scores (P,0.05). There was a 
significant difference between pharmacists attitude mean 
score (9.62±2.50) and pharmacy technicians attitude mean 
score (6.56±1.79) (P,0.05). All pharmacists had a posi-
tive attitude while only 68 (43%) of pharmacy technicians 
had a positive attitude toward pharmacovigilance and 
ADR reporting. Table 2 shows the comparison between 
pharmacists and pharmacy technicians in terms of attitude 
related questions.
association between good knowledge 
and positive attitude
The findings of this study showed that there was a signifi-
cant association (P,0.05) between good knowledge and a 
positive attitude toward reporting ADRs.
Table 2 Comparison between pharmacists and pharmacy technicians in terms of attitude related questions
Attitude questions Pharmacists,
(N=21), 
n (%)
Pharmacy 
technicians
(N=158), 
n (%)
P-value
i believe that pharmacovigilance is important 13 (61.9) 68 (43) 0.110*
Reporting aDRs is part of the professional duties of a pharmacist/pharmacy technician 16 (76.2) 43 (27.2) ,0.05*
i have to be sure the aDR is related to the drug before reporting 21 (100) 137 (86.7) 0.140*
i do not report aDRs of OTC products supplied by my pharmacy 5 (23.8) 2 (1.3) ,0.05*
i report an aDR that causes:
hospitalization 21 (100) 151 (95.6) 1.000*
a life-threatening situation 21 (100) 151 (95.6) 1.000*
a congenital anomaly 21 (100) 151 (95.6) 1.000*
Persistent disability or incapacity 21 (100) 151 (95.6) 1.000*
Death of the patient 21 (100) 151 (95.6) 1.000*
i report to get more insight into aDR questions that i come across in my practice 5 (23.8) 4 (2.5) ,0.05*
i report to show the patient that their concern is being taken seriously 5 (23.8) 4 (2.5) ,0.05*
i will report aDRs because it is part of pharmaceutical care 16 (76.2) 20 (12.7) ,0.05*
Consulting the physician is important before reporting an aDR 16 (76.2) 3 (1.9) ,0.05*
Total score, mean ± sD 9.62±2.500 6.56±1.790 ,0.05**
Positive attitude score 21 (100) 68 (43) ,0.05*
Notes: *Chi-square test or Fisher’s exact test; **independent t-test.
Abbreviations: aDRs, adverse drug reactions; OTC, over the counter.
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Barriers of aDR reporting
There was a significant difference between pharmacists and 
pharmacy technicians in terms of reported barriers in this 
study (Table 3). The most commonly given reasons for not 
reporting ADRs by community pharmacists were: “I don’t 
report because I find it difficult to admit that the patient has 
been harmed” (100%); “I don’t report because reporting may 
give the impression that I am ignorant concerning ADRs” 
(100%) and “All serious ADRs are detected before registra-
tion” (76.2%). The most commonly given reasons for not 
reporting ADRs by pharmacy technicians were reported: 
“All serious ADRs are detected before registration” (99.4%); 
“Reporting ADRs is time consuming” (98.9%); “I don’t report 
ADR because reporting forms are not available” (92.4%); 
“I don’t report because I have insufficient clinical knowledge” 
(80.4%) and “I don’t report ADRs because I don’t know the 
address where these reports should be sent” (92.4%). Table 3 
shows the comparison between pharmacists and pharmacy 
technicians in terms of barriers related questions.
Factors encouraging aDR reporting
The findings of this study showed that the factors to encour-
age ADRs reporting were attending course or workshops, 
educational materials, more attention to ADR reporting in 
pharmacy curriculum, simplification of reporting procedure, 
and promoting reporting as a part of professional duty. 
Table 4 shows the comparison between pharmacists and 
pharmacy technicians in terms of factors encouraging ADRs 
reporting questions.
Discussion
This study aimed to investigate the knowledge, attitude and 
barriers of both community pharmacists and pharmacy tech-
nicians toward pharmacovigilance, ADRs and ADR reporting 
in Yemen. This issue is very important to research in order 
to identify the required interventions so that the spontaneous 
ADR reporting can be improved, as both pharmacists and 
pharmacy technicians cannot participate effectively in ADR 
reporting without sufficient knowledge about pharmacovigi-
lance and reporting process.
The concept of pharmacovigilance in Yemen is relatively 
new as until recently there was only a minimum exposure 
Table 3 Comparison between pharmacists and pharmacy technicians in terms of barriers to aDR reporting questions
Barrier to ADRs reporting questions Pharmacists
(N=21), 
Agree; n (%)
Pharmacy 
technicians
(N=158), 
Agree; n (%)
i don’t report aDRs because reporting form is not available 6 (28.6) 146 (92.4)
i don’t report aDRs because i don’t know the address where these reports should be sent 9 (42.9) 146 (92.4)
The reporting form is too complicated 8 (38.1) 125 (79.1)
Reporting aDRs is time consuming 8 (38.1) 142 (98.9)
all serious aDRs are detected before registration 16 (76.2) 157 (99.4)
i don’t report aDRs because i want to publish about them myself 2 (9.5) 158 (100)
I don’t report ADRs because I am not convinced about the confidential handling of the reports 2 (9.5) 18 (11.4)
I don’t report ADRs because I fear it may harm the confidence of my patients 3 (14.3) 91 (57.6)
I don’t report because I find it difficult to admit that the patients have been harmed 21 (100) 19 (12)
i don’t report because reporting may give the impression that i am ignorant concerning aDRs 21 (100) 17 (10.8)
i don’t report because i fear legal liability for the reported aDRs 4 (19) 12 (7.6)
i am not motivated to report 10 (47.6) 132 (83.5)
I don’t report because I have insufficient clinical knowledge 3 (14.3) 127 (80.4)
i don’t report because i don’t know how to report aDRs 16 (76.2) 147 (93)
i don’t report because i am not convinced the aDRs is caused by the drug 8 (38.1) 119 (75.3)
Abbreviation: aDRs, adverse drug reactions.
Table 4 Comparison between pharmacists and pharmacy 
technicians in terms of factors that encourage aDRs reporting
Factors encouraging ADR 
reporting
Pharmacists
(N=21),
Agree; n (%)
Pharmacy 
technicians
(N=158),
Agree; n (%)
i will report if:
i attended courses or workshops to 
understand the reporting process
21 (100) 127 (80.4)
i received materials to understand 
the reporting process
21 (100) 127 (80.4)
aDR reporting is taught in university 21 (100) 158 (100)
The reporting procedure is simplified 21 (100) 124 (87.5)
it is part of the professional duty 21 (100) 158 (100)
There is an incentive 10 (47.6) 132 (83.5)
i receive more feedback through 
mailings
13 (61.9) 34 (21.5)
it is a compulsory report 15 (71.4) 57 (36.1)
Abbreviation: aDRs, adverse drug reactions.
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given during the training of pharmacy or medical students. 
The national Yemeni Pharmacovigilance Centre was only 
established in early 2011, which is considered late in com-
parison to other countries in the region. Few studies have 
investigated the knowledge, attitude and practice of com-
munity pharmacists toward ADRs and its reporting in Arabic 
countries, with none of these studies in Yemen.7,19,20
The results of this study show that the majority of com-
munity pharmacies in Yemen is run by pharmacy techni-
cians (88.7%), which is consistent with previous reports.10,11 
These reports state that pharmacy practice in Yemen faces 
major challenges to move toward providing better pharma-
ceutical care due to a number of reasons including that the 
number of pharmacists working in community pharmacies 
is insuffiecent.10,11 The results of these studies show that the 
majority of pharmacists and pharmacy technicians in Yemeni 
community pharmacies were male (98.3%), which is similar 
to a previous study,21 and could be due to the fact that 70% 
of pharmacy students in Yemen are males.
Knowledge about pharmacovigilance, 
aDRs and aDR reporting in Yemen
Only five pharmacists (23.8%) had a good knowledge toward 
pharmacovigilance, ADRs and ADR reporting, while no 
pharmacy technicians met the “good knowledge” criteria. 
This is a similar finding with studies from other Arabic coun-
tries in terms of poor knowledge among pharmacists.19,20,22–24 
However, the current study differs from these other studies 
in design and sample size. This study also included mixed 
qualitative and quantitative analysis along with including 
pharmacy technicians due to the nature of the pharmacy 
practice in Yemeni community pharmacies being different 
from other Arabic countries.10
experience of community pharmacy 
technicians in Yemen with aDRs and 
its reporting
The findings of this study showed that there were only nine 
pharmacists (42.9%) who observed ADRs in their practice. 
The most common ADRs they detected were allergy and 
diarrhea. However, they did not report these ADRs. This 
finding is different from studies undertaken in other Arabic 
countries19,20,22–24 in terms of reporting ADRs. This could be 
due to the Yemeni Pharmacovigilance Centre only being 
established in Sana’a early 2011 which has faced challenges 
in reporting and marketing its activities.12
attitude of community pharmacy 
technicians in Yemen toward 
pharmacovigilance and aDRs reporting
There was a significant difference between pharmacists and 
pharmacy technicians in terms of positive attitude toward 
pharmacovigilance (P,0.05). All pharmacists had a posi-
tive attitude while only 68 (43%) pharmacy technicians had 
a positive attitude toward pharmacovigilance and ADR 
reporting. This was due to the difference in knowledge 
between pharmacists and pharmacy technicians. As expected, 
the finding of this study showed a significant association 
(P,0.05) between good knowledge and positive attitude 
toward reporting ADRs. This finding is in line with that of 
a study conducted in Saudi Arabia by Bawazir in terms of 
attitude of community pharmacists toward ADR reporting 
by pharmacists.22 A difference in attitude between pharmacy 
technicians in Yemen and community pharmacists reported 
by Bawazir in Saudi Arabia22 was observed, possibly due to 
the nature of pharmacy practice in community pharmacies 
being different.
encouraging aDR reporting
Similar to other countries,22–24 this study provides strong 
evidence of ADR under-reporting in Yemen. More efforts 
should be taken by the Pharmacovigilance Centre in Yemen 
to improve the awareness of health care professionals on 
benefits and risk of medicines, and thus, practice rational 
prescription of drugs and implement ADR reporting. In addi-
tion, patients should also be equipped with better knowledge 
of the consequences of drug use, and thus, using drugs more 
appropriately. ADR reporting can be promoted in many ways, 
such as distributing manuals on ADR reporting to all medi-
cal practitioners and pharmacists. ADR reporting forms with 
prepaid postage could be given free to doctors and pharmacists 
or online reporting system could be implemented. Educational 
talks, bulletins and annual-reports on ADRs could be distrib-
uted to public and private sector doctors and pharmacists.
limitations of the study
The current study has several limitations. This study was 
conducted in the capital, Sana’a, only, therefore the findings 
cannot be generalized to all Yemeni community pharmacists 
and pharmacy technicians. Another limitation is the small 
sample size of pharmacists included in this study. This is an 
intrinsic problem because of gross shortage of pharmacists 
in Yemen.
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Conclusion
Pharmacists have significantly better knowledge than phar-
macy technicians with regard to pharmacovigilance. More 
than half of pharmacy technicians also showed a negative 
attitude toward ADR reporting. Therefore, educational 
interventions and training is very important for community 
pharmacists and pharmacy technicians in Yemen to increase 
their awareness and participation in ADR reporting.
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